Roche Leads $254 Million Investment in Freenome, Marking a Major Milestone in Cancer Early Detection

Haoyue Values

MissionEmpower with Capital, Build an Excellent Healthcare Enterprise

VisionTo become the most outstanding investment bank in China's healthcare industry

HaoYue Capital, founded in January 2014, is a leading investment bank in China that focuses on the healthcare industry. Headquartered in Shanghai, the company has regional offices in Beijing, Shenzhen, and Hong Kong. HaoYue Capital is committed to leveraging capital and research-driven insights to help outstanding enterprises in China's healthcare sector successfully access the capital markets and create added value for clients. The partnership team at HaoYue Capital comprises seasoned investment bankers with extensive experience in China’s healthcare industry. HaoYue Capital continuously tracks developments and investment trends in the healthcare market, covering research areas and transactions involving innovative pharmaceuticals, advanced medical devices, IVD and life sciences, health services, and digital healthcare across various specialized segments. As of 2023, HaoYue Capital has completed nearly 400 projects with a total transaction value exceeding tens of billions of US dollars, including over 50 mergers and acquisitions totaling more than 50 billion US dollars. In 2023 alone, HaoYue Capital executed nearly 50 private equity financings, M&A integrations, and complex spin-off transactions from publicly listed companies, with a combined transaction value amounting to several billion US dollars, maintaining its leadership across all sub-sectors of the healthcare industry.